Pages that link to "Q34227743"
Jump to navigation
Jump to search
The following pages link to Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. (Q34227743):
Displaying 50 items.
- Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference (Q24563464) (← links)
- Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions (Q24646942) (← links)
- FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells (Q24650419) (← links)
- The emerging role of FTY720 (Fingolimod) in cancer treatment (Q26748927) (← links)
- Sphingolipid signaling in metabolic disorders (Q26992148) (← links)
- S1P control of endothelial integrity (Q27000974) (← links)
- Lipid phosphate phosphatase (LPP3) and vascular development (Q27002640) (← links)
- Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy (Q27011473) (← links)
- Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier (Q27322655) (← links)
- Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants (Q27343108) (← links)
- Lipid phosphate phosphatases and their roles in mammalian physiology and pathology (Q28088430) (← links)
- FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis (Q28288357) (← links)
- Pathophysiological Consequences of a Break in S1P1-Dependent Homeostasis of Vascular Permeability Revealed by S1P1 Competitive Antagonism (Q28555184) (← links)
- Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization (Q28589943) (← links)
- FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model (Q29248124) (← links)
- Bioactive lipid coating of bone allografts directs engraftment and fate determination of bone marrow-derived cells in rat GFP chimeras (Q30279090) (← links)
- Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3 (Q30405763) (← links)
- Delivery of S1P receptor-targeted drugs via biodegradable polymer scaffolds enhances bone regeneration in a critical size cranial defect (Q30406089) (← links)
- Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration (Q30416979) (← links)
- Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors (Q30417604) (← links)
- Selective Activation of Sphingosine 1-Phosphate Receptors 1 and 3 Promotes Local Microvascular Network Growth (Q30428199) (← links)
- S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor (Q30434737) (← links)
- Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720. (Q30438675) (← links)
- Targeting sphingosine 1 phosphate receptor type 1 receptors in acute kidney injury (Q30439643) (← links)
- Engineering vascularized tissues using natural and synthetic small molecules (Q30439954) (← links)
- Follicular shuttling of marginal zone B cells facilitates antigen transport (Q30441344) (← links)
- The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches. (Q30479623) (← links)
- Fingolimod treatment in multiple sclerosis leads to increased macular volume (Q30537200) (← links)
- Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning (Q33615222) (← links)
- Coadministration of FTY720 and rt-PA in an experimental model of large hemispheric stroke-no influence on functional outcome and blood-brain barrier disruption (Q33643959) (← links)
- Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations. (Q33651898) (← links)
- Simvastatin-induced sphingosine 1-phosphate receptor 1 expression is KLF2-dependent in human lung endothelial cells (Q33738580) (← links)
- Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis (Q33756825) (← links)
- Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility (Q33872502) (← links)
- Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient (Q33880223) (← links)
- Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics (Q33979875) (← links)
- Potential Agents against Plasma Leakage (Q34074737) (← links)
- Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion (Q34113032) (← links)
- Sphingosine 1-phosphate and cancer (Q34121255) (← links)
- FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells (Q34162587) (← links)
- Extracellular and Intracellular Actions of Sphingosine-1-Phosphate (Q34183703) (← links)
- Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung (Q34184813) (← links)
- Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury (Q34357097) (← links)
- Virus interactions with endothelial cell receptors: implications for viral pathogenesis (Q34388874) (← links)
- Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. (Q34546048) (← links)
- Cardiovascular effects of fingolimod: A review article. (Q34558943) (← links)
- Individual variation of human S1P₁ coding sequence leads to heterogeneity in receptor function and drug interactions (Q34565310) (← links)
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis (Q34624835) (← links)
- Sphingosine‐1‐phosphate antibodies as potential agents in the treatment of cancer and age‐related macular degeneration (Q34678040) (← links)
- Evidence-based assessment of potential use of fingolimod in treatment of relapsing multiple sclerosis (Q34729032) (← links)